Preclinical Drug Development
- Preclinical safety and efficacy studies
- Ex vivo immunologic testing using TruCulture™
- Drug Binding Studies
- Genotoxicity testing
- Irwin Test
- ADME testing
- In vitro HIV-1 testing
- API batch process methods
- Identification of novel activities
- Development of a diagnostic assay
- Cotherapeutic testing
- Comparative testing
- Preclinical dose-finding studies
Funding
SBIR Phase II NIH/NIMH Grant Award: Safety and Efficacy Testing of FX101 in an SIV/NHP Model
SBIR Phase I NIH/NIAID Grant Award: Standardizable Whole Blood Culture for Evaluating HIV Eradication Strategies
SBIR Phase I NIH/NIMH Grant Award: FIV Testing of a CNS-Relevant Antiretroviral Compound
SBIR Phase I NIH/NIMH Grant Award: A Novel CNS-Penetrable Antiretroviral
Intellectual Property
Nonprovisional PCT application Methods for Viral Infections filed Feb 28, 2023.
Utilities of stimulated whole blood culture systems. US 10,550,419 · Issued Feb 4, 2020
Lipid Raft, Caveolin Protein and Caveolar Function Modulation Compounds and Associated Synthetic and Therapeutic Methods. US 9,132,115 · Issued Sep 15, 2015
Platinum (IV) Compounds Targeting Zinc Finger Domains. US 8,895,610 · Issued Nov 25, 2014
Lipid Raft, Caveolin Protein and Caveolar Function Modulation Compounds and Associated Synthetic and Therapeutic Methods. US 8,425,921 · Issued April 23, 2013
Lipid Raft, Caveolin Protein and Caveolar Function Modulation Compounds and Associated Synthetic and Therapeutic Methods. US 8,026,382 · Issued Sept 27, 2011